BioVie Inc.

BIVI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $-2.4M $-1.3M $-431.9K $-233.0K $-321.9K $-17.5K
Depreciation & Amortization — — — — — —
Depreciation — — — — — —
Amortization $229.4K $229.4K $51.0K — — —
Stock-Based Compensation $238.2K — — — — —
Net Cash from Operating Activities $-621.3K $-623.6K $-153.6K $-65.4K $-172.8K $-2.5K
Investing Activities
Capital Expenditures — — — — — —
Business Acquisitions — — — — — —
Net Cash from Investing Activities — — $9.9K — — —
Financing Activities
Dividends Paid — — — — — —
Stock Repurchases — — — — — —
Net Cash from Financing Activities $662.0K $505.0K $-5 — — $508.2K
Net Change in Cash $40.7K $-118.6K $-143.7K $-65.4K $-172.8K $505.7K
Free Cash Flow — — — — — —
← Newer Page 2 of 2 Older →